NSPR
InspireMD, Inc. NASDAQ$1.17
Mkt Cap $54.8M
52w Low $1.05
6.4% of range
52w High $2.93
50d MA $1.54
200d MA $1.98
P/E (TTM)
-1.5x
EV/EBITDA
-2.6x
P/B
1.5x
Debt/Equity
0.0x
ROE
-88.4%
P/FCF
-3.6x
RSI (14)
—
ATR (14)
—
Beta
0.94
50d MA
$1.54
200d MA
$1.98
Avg Volume
40.1K
About
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems f…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | AMC | -0.19 | -0.16 | +15.8% | — | — | — | — | — | — | — | — | — |
| Mar 18, 2026 | AMC | -0.22 | -0.14 | +36.4% | 1.79 | +0.0% | -4.5% | +1.1% | -2.8% | +0.0% | -1.1% | -24.6% | — |
| Nov 4, 2025 | AMC | -0.17 | -0.17 | +0.0% | 2.13 | +0.0% | -0.9% | -8.0% | -15.0% | -21.1% | -23.5% | -9.9% | — |
| Aug 4, 2025 | AMC | -0.24 | -0.26 | -8.3% | 2.67 | +1.1% | -8.2% | -6.4% | -10.5% | -9.4% | -3.4% | -9.0% | — |
| May 9, 2025 | AMC | -0.17 | -0.22 | -29.4% | 2.60 | +1.9% | -0.8% | -6.5% | -9.2% | -8.8% | -9.2% | -7.7% | — |
| Mar 12, 2025 | AMC | -0.20 | -0.19 | +5.0% | 2.81 | +1.4% | +2.1% | -0.4% | -0.4% | -0.4% | -0.4% | -8.9% | — |
| Nov 12, 2024 | AMC | -0.20 | -0.16 | +20.0% | 2.38 | -10.9% | +5.5% | +7.1% | +6.3% | +8.8% | +8.0% | +29.8% | — |
| Aug 6, 2024 | AMC | -0.19 | -0.22 | -15.8% | 2.98 | -1.7% | -4.0% | -4.4% | -4.0% | -4.7% | -1.0% | -8.1% | — |
| May 14, 2024 | AMC | -0.15 | -0.21 | -40.0% | 2.38 | -0.8% | -3.4% | -3.4% | -3.4% | -4.2% | -2.1% | +9.2% | — |
| Mar 6, 2024 | AMC | -0.20 | -0.16 | +20.0% | 2.53 | -2.8% | +4.3% | +4.0% | +0.8% | -2.8% | -1.2% | -9.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.60 | $2.65 | +1.9% | -0.8% | -6.5% | -9.2% | -8.8% | -9.2% |
| Nov 2 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.77 | $3.29 | -12.7% | -11.4% | -8.6% | -11.4% | -14.1% | -14.1% |
| Jun 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $1.69 | $1.90 | +12.4% | +7.7% | +9.5% | +17.8% | +21.3% | +40.8% |
| May 17 | National Alliance Securities | Maintains | Buy → Buy | — | $1.68 | $1.76 | +4.8% | +4.8% | +1.2% | +7.1% | +13.1% | +5.4% |
| Mar 31 | Alliance Global Partners | Maintains | Buy → Buy | — | $1.06 | $1.07 | +0.9% | +6.6% | +1.9% | +1.9% | +7.5% | +2.8% |
| Mar 11 | H.C. Wainwright | Maintains | Buy → Buy | — | $9.90 | $9.15 | -7.6% | -3.0% | -16.7% | -19.7% | -24.2% | -24.2% |
| Mar 29 | Rodman & Renshaw | Maintains | Buy → Buy | — | $248437.50 | $257812.50 | +3.8% | -3.8% | -1.9% | -3.8% | -5.7% | -9.4% |
| Jan 7 | H.C. Wainwright | Maintains | Buy → Buy | — | $332812.50 | $370312.50 | +11.3% | +0.0% | +15.5% | +12.7% | -1.4% | -1.4% |
| Mar 13 | Oppenheimer | Downgrade | Outperform → Perform | — | — | — | — | — | — | — | — | — |
| Nov 26 | Oppenheimer | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
Recent Filings
8-K · 8.01
!! High
InspireMD, Inc. -- 8-K 8.01: Material Event / Announcement
InspireMD filed an 8-K to disclose material press releases, though the specific announcement details aren't fully summarized in the filing excerpt provided.
May 1
8-K · 1.01
!! High
Unknown — 8-K 1.01: Distribution Agreement
NSPR signed a distribution agreement with BTIG, likely expanding market access and trading liquidity for the stock, which could reduce spreads and attract institutional investors.
Apr 3
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
NSPR disclosed material non-public information via Regulation FD, suggesting the company made an unexpected announcement that could significantly impact stock valuation and trading, requiring immediate investor attention.
Mar 18
8-K · 5.02
!!! Very High
InspireMD, Inc. -- 8-K 5.02: Executive Change
InspireMD's executive Tommasoli remains employed under a French contract with six-month dismissal notice requirements, potentially limiting the company's flexibility in personnel changes.
Mar 4
Data updated apr 26, 2026 3:51pm
· Source: massive.com